A Comprehensive Generic Drug Naming Resource
Deciphering generic drug names using the World Health Organization international nonproprietary names system Drugs have several types of names, as […]
Deciphering generic drug names using the World Health Organization international nonproprietary names system Drugs have several types of names, as […]
Biosimilars are expected to bring down costs of innovative treatments for conditions like cancer and autoimmune diseases “Biologics” are some
Predicting Patent Litigation Outcomes for Biosimilars Read Post »
Are protections in place to prevent bribing of FDA officials? With drugs such as Lipitor achieving lifetime sales well over
IT and software technologies attract the most patent lawsuits, but pharmaceuticals are targeted too In the US, patent infringement cases
This is part six of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted
Strategies for Branded Drug Lifecycle Management: Part 6 – Summary and Conclusion Read Post »
This is part five of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted
Strategies for Branded Drug Lifecycle Management: Part 5 – Adaptation Read Post »
This is part four of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted
Strategies for Branded Drug Lifecycle Management: Part 4 – Extraction Read Post »
This is part three of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted
Strategies for Branded Drug Lifecycle Management: Part 3 – Innovation Read Post »
This is part two of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted
Strategies for Branded Drug Lifecycle Management: Part 2 – Prevention Read Post »